Recurrence: all 3,523 studies

Page 14 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaCompletedNCT00998946Phase 2Results posted
• Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)CompletedNCT00989261Phase 2Results posted
• Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNCT00984165Phase 2Results posted
• Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LLTerminatedNCT00981799Phase 1/2Results posted
• Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)TerminatedNCT00978432Phase 2Results posted
• Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility StudyTerminatedNCT00968799Not applicableResults posted
• Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory LymphomaCompletedNCT00967044Phase 1/2Results posted
• Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00963105Phase 2Results posted
• CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)CompletedNCT00955916Phase 2Results posted
• A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00949988Phase 1/2Results posted
• Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With CancerTerminatedNCT00949117Phase 2Results posted
• Relapse Prevention With VareniclineCompletedNCT00944554Phase 4Results posted
• T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)TerminatedNCT00939653Phase 2Results posted
• LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's MacroglobulinemiaCompletedNCT00936611Phase 2Results posted
• Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple MyelomaCompletedNCT00932698Phase 1Results posted
• Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)TerminatedNCT00928200Phase 1Results posted
• STRIDE - STimulating Immune Response In aDvanced brEast CancerTerminatedNCT00925548Phase 3Results posted
• Medication-overuse Headache: 4 Years Follow upCompletedNCT00918671Results posted
• Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple SclerosisCompletedNCT00906399Phase 3Results posted
• Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute SchizophreniaCompletedNCT00905307Phase 2Results posted
• Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple MyelomaCompletedNCT00903968Phase 1/2Results posted
• A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)CompletedNCT00882999Phase 2Results posted
• TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaCompletedNCT00867568Phase 1Results posted
• Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaCompletedNCT00867529Phase 2Results posted
• Study of Pemetrexed for Second-Line Pancreas CancerTerminatedNCT00864513Phase 2Results posted
• Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse RiskCompletedNCT00861146Phase 2Results posted
• Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersCompletedNCT00856388Not applicableResults posted
• Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian OriginTerminatedNCT00840450Phase 2Results posted
• BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)CompletedNCT00835770Phase 3Results posted
• Long-term Varenicline Treatment for Smoking CessationCompletedNCT00828113Phase 4Results posted
• Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00824746Phase 2Results posted
• Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic LeukemiaCompletedNCT00824265Phase 3Results posted
• Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT00823719Phase 2Results posted
• Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)CompletedNCT00822094Phase 2Results posted
• Trial on Lenalidomide Given as Maintenance Therapy for Relapsed Diffuse Large B Cell LymphomaCompletedNCT00799513Phase 2Results posted
• Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantCompletedNCT00795769Phase 2Results posted
• Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsTerminatedNCT00788125Phase 1/2Results posted
• Study of Vorinostat (MK0683), an Histone Deacetylase (HDAC) Inhibitor in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (MK-0683-095)CompletedNCT00773838Phase 2Results posted
• Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell CancerCompletedNCT00768664Phase 2Results posted
• A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00756444Phase 2Results posted
• A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the LungTerminatedNCT00752206Phase 2Results posted
• Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.TerminatedNCT00744653Phase 2Results posted
• A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced SarcomaCompletedNCT00743509Phase 2Results posted
• Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal CarcinomaCompletedNCT00729053Phase 2Results posted
• Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary BladderCompletedNCT00722553Phase 2Results posted
• Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other DiseaseTerminatedNCT00719849Phase 2Results posted
• Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid LeukemiaCompletedNCT00718159Phase 1Results posted
• Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)CompletedNCT00713193Phase 3Results posted
• Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT00705016Phase 1/2Results posted
• Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis CCompletedNCT00695019Phase 2Results posted
• T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic MalignanciesCompletedNCT00683046Phase 2Results posted
• Study of Natalizumab in Relapsed/Refractory Multiple MyelomaTerminatedNCT00675428Phase 1/2Results posted
• Limberg-flap: Prospective Data CollectionCompletedNCT00672555Not applicableResults posted
• Epidemiology of Thromboembolism Disease: A Cohort StudyCompletedNCT00670540Results posted
• A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerCompletedNCT00661609Phase 2Results posted
• Ph2 Gem/Nov/Rituxan Rel/Ref MantleCellCompletedNCT00656084Phase 2Results posted
• Clinical Efficacy of Sertraline Augmented With Gabapentin in Depressed, Recently Abstinent Cocaine-dependent HumansCompletedNCT00654953Phase 2Results posted
• Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)CompletedNCT00642954Phase 1Results posted
• PRET: Patients Prone to Recurrence After Endovascular TreatmentCompletedNCT00626912Phase 4Results posted
• Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple SclerosisCompletedNCT00622700Phase 3Results posted
• Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantTerminatedNCT00617929Phase 2Results posted
• Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning RegimenTerminatedNCT00615589Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaCompletedNCT00612716Phase 2Results posted
• Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemTerminatedNCT00612677Phase 2Results posted
• An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant MesotheliomaTerminatedNCT00597116Phase 2Results posted
• New Therapy of Laryngeal Papilloma In ChildrenTerminatedNCT00591305Not applicableResults posted
• Combining Medications to Enhance Depression OutcomesCompletedNCT00590863Phase 4Results posted
• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerCompletedNCT00589563Phase 2Results posted
• Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid TumorsTerminatedNCT00582816Phase 1/2Results posted
• Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin LymphomaCompletedNCT00574496Phase 2Results posted
• Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's LymphomaCompletedNCT00547534Phase 2Results posted
• Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal CarcinomaCompletedNCT00545545Phase 1/2Results posted
• Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel TrialCompletedNCT00545181Not applicableResults posted
• Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersActive, not recruitingNCT00544115Phase 2Results posted
• Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in HumansCompletedNCT00541866Phase 1/2Results posted
• Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple MyelomaTerminatedNCT00538824Phase 2Results posted
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
• Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma PatientsCompletedNCT00536575Phase 1/2Results posted
• Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell TransplantCompletedNCT00534118Not applicableResults posted
• CT-011 MAb in DLBCL Patients Following ASCTCompletedNCT00532259Phase 2Results posted
• Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain TumorsCompletedNCT00528437Phase 2Results posted
• Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple MyelomaCompletedNCT00511238Phase 2Results posted
• Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT00509145Phase 3Results posted
• Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00495079Phase 2Results posted
• Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple SclerosisCompletedNCT00489489Phase 2Results posted
• Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesCompletedNCT00481871Phase 1/2Results posted
• A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent GliomaTerminatedNCT00479765Phase 1/2Results posted
• A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00478777Phase 3Results posted
• Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple SclerosisCompletedNCT00475865Phase 2Results posted
• Abatacept in Treating Adults With Mild Relapsing Wegener's GranulomatosisCompletedNCT00468208Phase 1/2Results posted
• A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple MyelomaTerminatedNCT00464178Phase 2Results posted
• A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 StatusCompletedNCT00462761Phase 1Results posted
• Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple MyelomaCompletedNCT00461045Phase 2Results posted
• PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of ResponseCompletedNCT00454779Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesCompletedNCT00453206Not applicableResults posted
• Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple SclerosisCompletedNCT00451451Phase 3Results posted
• Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseCompletedNCT00448201Phase 2Results posted
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesCompletedNCT00441337Phase 1Results posted
• Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple MyelomaTerminatedNCT00441168Phase 2Results posted
• Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)CompletedNCT00440726Phase 1/2Results posted

← Recurrence overview